Samuel R. Denmeade
0000-0001-5442-515X
Publication & Citation Trends
Most Cited Works
Publications
556 total
Clinical characteristics and long-term outcomes of extreme responders to first line treatment of metastatic prostate cancer.
Cited by 0
Semantic Scholar
WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide.
Cited by 0
Semantic Scholar
Bipolar androgen therapy as platform for personalized medicine in castration-resistant prostate cancer
Cited by 0
Semantic Scholar
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.
Cited by 0
Semantic Scholar
Effect of enzalutamide and bipolar androgen therapy on clonal hematopoiesis and clinical outcomes among men with metastatic castration resistant prostate cancer.
Cited by 0
Semantic Scholar
Abstract B042: Enhancing ferroptosis in supraphysiologic androgen–treated prostate cancer through GPX4 inhibition
Cited by 0
Semantic Scholar
Castration Resistance Accelerates Prostate Cancer Kinetics
Cited by 0
Semantic Scholar
Abstract 2587: Development of a methylated gene panel for detection of cell-free, metastatic prostate cancer DNA in plasma
Cited by 0
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(250)
Vitamin C and Antioxidants Research
(111)
Cancer, Lipids, and Metabolism
(88)
Prostate Cancer Diagnosis and Treatment
(86)
Radiopharmaceutical Chemistry and Applications
(63)
Frequent Co-Authors
Affiliations
University of Copenhagen
St. Jude Children's Research Hospital
Beth Israel Deaconess Medical Center
Memorial Sloan Kettering Cancer Center
Janssen (Belgium)